282 related articles for article (PubMed ID: 36782236)
1. Prioritization of head and neck cancer patient care during the COVID-19 pandemic: a retrospective cohort study.
Psycharis SS; Salameh S; Turkdogan S; Razzaq S; Zhao K; Mascarella MA; Richardson K; Mlynarek AM; Hier MP; Sadeghi N
J Otolaryngol Head Neck Surg; 2023 Feb; 52(1):15. PubMed ID: 36782236
[TBL] [Abstract][Full Text] [Related]
2. The impact and prevalence of SARS-CoV-2 in patients with head and neck cancer and acute upper airway infection in a tertiary otorhinolaryngology referral center in Denmark.
Andersen PA; Rasmussen KMB; Channir HI; von Buchwald C; Cayé-Thomasen P; Klokker M; Knudsen JD; Kirkby NS; Aanaes K; Jensen RG
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3409-3415. PubMed ID: 33388982
[TBL] [Abstract][Full Text] [Related]
3. Impact of COVID-19 pandemic on head-neck cancer referral and treatment pathway in North East London.
Zubair A; Jamshaid S; Scholfield DW; Hariri AA; Ahmed J; Ghufoor K; Ali S
Ann R Coll Surg Engl; 2023 Aug; 105(S2):S28-S34. PubMed ID: 35446702
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a Surgical Prioritization and Ranking Tool and Navigation Aid for Head and Neck Cancer (SPARTAN-HN) in a scarce resource setting: Response to the COVID-19 pandemic.
de Almeida JR; Noel CW; Forner D; Zhang H; Nichols AC; Cohen MA; Wong RJ; McMullen C; Graboyes EM; Divi V; Shuman AG; Rosko AJ; Lewis CM; Hanna EY; Myers J; Paleri V; Miles B; Genden E; Eskander A; Enepekides DJ; Higgins KM; Brown D; Chepeha DB; Witterick IJ; Gullane PJ; Irish JC; Monteiro E; Goldstein DP; Gilbert R
Cancer; 2020 Nov; 126(22):4895-4904. PubMed ID: 32780426
[TBL] [Abstract][Full Text] [Related]
5. The Impact of the COVID-19 Pandemic on Head and Neck Cancer Diagnosis in the Piedmont Region, Italy: Interrupted Time-Series Analysis.
Popovic M; Fiano V; Moirano G; Chiusa L; Conway DI; Garzino Demo P; Gilardetti M; Iorio GC; Moccia C; Ostellino O; Pecorari G; Ramieri G; Ricardi U; Riva G; Virani S; Richiardi L
Front Public Health; 2022; 10():809283. PubMed ID: 35265573
[TBL] [Abstract][Full Text] [Related]
6. Treatment prioritization and risk stratification of head and neck cancer during COVID-19 pandemic: A systematic review.
Adham M; Anam K; Reksodiputro L
Med J Malaysia; 2022 Jan; 77(1):53-59. PubMed ID: 35086995
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 impact on the management of head and neck cancer: a French single-centre experience.
Clementine M; Camille C; Swann A; Alavi Z; Remi M; Jean-Christophe L
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):873-882. PubMed ID: 37845381
[TBL] [Abstract][Full Text] [Related]
8. A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group.
De Felice F; D'Angelo E; Ingargiola R; Iacovelli NA; Alterio D; Franco P; Bonomo P; Merlotti A; Bacigalupo A; Maddalo M; Di Rito A; Fanetti G; D'Onofrio I; Dionisi F; Miccichè F; Trignani M; Musio D; Paiar F; Romanello DA; Donato V; Orlandi E
Radiol Med; 2021 Feb; 126(2):343-347. PubMed ID: 33025304
[TBL] [Abstract][Full Text] [Related]
9. The COVID-19 pandemic and its consequences for the diagnosis and therapy of head and neck malignancies.
Balk M; Rupp R; Craveiro AV; Allner M; Grundtner P; Eckstein M; Hecht M; Iro H; Gostian AO
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):284-290. PubMed ID: 35049006
[TBL] [Abstract][Full Text] [Related]
10. The impact of COVID-19 on head and neck cancer diagnosis and disease extent.
Kiong KL; Diaz EM; Gross ND; Diaz EM; Hanna EY
Head Neck; 2021 Jun; 43(6):1890-1897. PubMed ID: 33650276
[TBL] [Abstract][Full Text] [Related]
11. Impact of the COVID-19 pandemic on head and neck cancer patients: systematic review and meta-analysis.
de Castro MS; Machado BMSM; Barbosa MCF; Soares LFF; Sperandio FF; de Carli ML; Pigossi SC; de Lima DC
Quintessence Int; 2023 Apr; 54(4):320-327. PubMed ID: 36799508
[TBL] [Abstract][Full Text] [Related]
12. The COVID-19 pandemic has not changed stage at presentation nor treatment patterns of head and neck cancer: A retrospective cohort study.
Clements K; Cowell A; White G; Flynn W; Conway DI; Douglas CM; Paterson C
Clin Otolaryngol; 2023 Jul; 48(4):587-594. PubMed ID: 36929626
[TBL] [Abstract][Full Text] [Related]
13. What is the best treatment option for head and neck cancers in COVID-19 pandemic? A rapid review.
Salari A; Jalaeefar A; Shirkhoda M
Am J Otolaryngol; 2020; 41(6):102738. PubMed ID: 32979663
[TBL] [Abstract][Full Text] [Related]
14. Impact of COVID-19 on Head and Neck Cancer Advancement Measured by Increasing Numbers of Urgent Dyspnea Cases-What Could Be Improved in the Event of Subsequent Pandemics?
Pietruszewska W; Burduk P; Rosiak O; Podlawska P; Zakrzewski B; Barańska M; Kowalczyk M; Piątkowski J; Śmigielski G; Solarz P; Staszak M; Wierzbicka M; Mikaszewski B
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362613
[TBL] [Abstract][Full Text] [Related]
15. UK Head and neck cancer surgical capacity during the second wave of the COVID-19 pandemic: Have we learned the lessons? COVIDSurg collaborative.
Shaw R;
Clin Otolaryngol; 2021 Jul; 46(4):729-735. PubMed ID: 33660920
[TBL] [Abstract][Full Text] [Related]
16. Delay in head and neck cancer care during the COVID-19 pandemic and its impact on health outcomes.
Mahl C; Melo LRS; Almeida MHA; Carvalho CS; Santos LLS; Nunes PS; Quintans-JÚnior LJ; AraÚjo AAS; Santos VS; Martins-Filho PR
Braz Oral Res; 2020; 34():e126. PubMed ID: 33331392
[TBL] [Abstract][Full Text] [Related]
17. Delayed presentation of head and neck cancer patients during COVID-19 pandemic.
Tevetoğlu F; Kara S; Aliyeva C; Yıldırım R; Yener HM
Eur Arch Otorhinolaryngol; 2021 Dec; 278(12):5081-5085. PubMed ID: 33674926
[TBL] [Abstract][Full Text] [Related]
18. Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS-CoV-2 (COVID19) pandemic.
Patel RJ; Kejner A; McMullen C
Head Neck; 2020 Jun; 42(6):1168-1172. PubMed ID: 32329923
[TBL] [Abstract][Full Text] [Related]
19. Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patients.
Chen G; Wu Q; Jiang H; Li Z; Hua X; Hu X; Yu H; Xie C; Zhong Y
J Hematol Oncol; 2020 Dec; 13(1):174. PubMed ID: 33308264
[TBL] [Abstract][Full Text] [Related]
20. Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: A nationwide population-based analysis.
Schoonbeek RC; de Jel DVC; van Dijk BAC; Willems SM; Bloemena E; Hoebers FJP; van Meerten E; Verbist BM; Smeele LE; Halmos GB; Merkx MAW; Siesling S; De Bree R; Takes RP;
Radiother Oncol; 2022 Feb; 167():42-48. PubMed ID: 34915063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
